Long-term treatment adherence to the proprotein convertase...

  • Main
  • 2017 / 6
  • Long-term treatment adherence to the proprotein convertase...
Journal of Clinical Lipidology 2017 / 6

Long-term treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in 6 ODYSSEY Phase III clinical studies with treatment duration of 1 to 2 years

Farnier, Michel, Colhoun, Helen M., Sasiela, William J., Edelberg, Jay M., Asset, Gaëlle, Robinson, Jennifer G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Clinical Lipidology
DOI:
10.1016/j.jacl.2017.05.016
Date:
June, 2017
File:
PDF, 1.03 MB
english, 2017
Conversion to is in progress
Conversion to is failed